Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

The pharmacokinetics of the prostaglandin E1 analogue misoprostol in plasma and colostrum after postpartum oral administration.

Authors:
Hany Abdel-Aleem José Villar A Metin Gülmezoglu Sayed A Mostafa Alaa A Youssef Mahmoud Shokry Bernhard Watzer

Eur J Obstet Gynecol Reprod Biol 2003 May;108(1):25-8

Department of Obstetrics and Gynecology, Assiut University Hospital, Assiut, Egypt.

Objective: To study pharmacokinetics of prostaglandin E1 analogue, misoprostol in plasma and colostrum after postpartum oral administration.

Study Design: Twenty women received 600 microg doses of misoprostol orally after delivery. Plasma levels of the principal metabolite, misoprostol acid, were measured at 2, 10, 20, 30, 40, 50, 60, 90, 120, 180, 240 and 300 min (48 samples). Colostrum was expressed from the breasts to measure misoprostol acid at 60, 120, 180, 240, and 300 min (24 samples). Assay was done using isotope dilution gas chromatography (GC)/negative ion chemical ionisation mass spectrometry (MS).

Results: The plasma concentration of misoprostol acid rose quickly. Two minutes after oral administration its mean level was 91.5 pg/ml, peaked at 20 min (344 pg/ml), then fell steeply by 120 min (27.8 pg/ml) and remained low for the duration of the study. Misoprostol acid in colostrum reached maximum concentration of 20.9 pg/m within 1h after oral administration. It then declined gradually to 17.8 pg/ml at 2h, 2.8 pg/ml at 4h and to <1 pg/ml at 5h. Areas under misoprostol concentration versus time curves up to 5h were 290.1 pgh/ml in the plasma and 51.4 pgh/ml in colostrum, respectively.

Conclusion: Misoprostol acid is secreted in colostrum within 1h of oral administration of 600 microg of misoprostol; the pharmacokinetics of misoprostol after oral administration during postpartum is similar to that of other pregnancy periods.

Download full-text PDF

 Source
http://dx.doi.org/10.1016/s0301-2115(02)00355-xDOI Listing
May 2003

Publication Analysis

Top Keywords

misoprostol acid
16
oral administration
12
colostrum postpartum
8
120 180
8
min samples
8
postpartum oral
8
240 300
8
180 240
8
300 min
8
plasma colostrum
8
prostaglandin analogue
8
pharmacokinetics prostaglandin
8
analogue misoprostol
8
misoprostol plasma
8
misoprostol
7
pg/ml
5
acid rose
4
expressed breasts
4
measure misoprostol
4
acid 120
4

Keyword Occurance

Similar Publications

A crossover pharmacokinetic study of misoprostol by the oral, sublingual and buccal routes.

Authors:
Laura J Frye Meagan E Byrne Beverly Winikoff

Eur J Contracept Reprod Health Care 2016 Aug 22;21(4):265-8. Epub 2016 Apr 22.

a Gynuity Health Projects , New York , NY , USA.

Objectives: The aim of the study was to compare the pharmacokinetic parameters of 800 μg oral, sublingual and buccal misoprostol in healthy non-pregnant women.

Methods: This was an open-label, randomised study with a three-way crossover design. Eighteen participants were randomly assigned to treatment sequences of 800 μg oral, sublingual and buccal misoprostol administered under fasting conditions, with a 7-day washout period. Read More

View Article and Full-Text PDF
August 2016
Similar Publications

Evaluating misoprostol content in pregnant women with hourly oral administration during labor induction by microElution solid phase extraction combined with liquid chromatography tandem mass spectrometry.

Authors:
Cheng-Han Hung Shi-Yann Cheng Tzu-Min Chan Maw-Rong Lee

J Chromatogr B Analyt Technol Biomed Life Sci 2015 Sep 17;1000:176-80. Epub 2015 Jul 17.

Department of Chemistry, National Chung Hsing University, Taichung 40227, Taiwan, ROC. Electronic address:

Misoprostol is a widely used alternative of prostaglandin for labor induction. Based on previous studies, we envision that small and frequent oral dosage of misoprostol is an effective method for labor induction. To monitor the misoprostol content during labor induction, a rapid, sensitive, and selective microElution solid phase extraction (μElution SPE) combined with liquid chromatography tandem mass spectrometry (LC-MS/MS) was developed. Read More

View Article and Full-Text PDF
September 2015
Similar Publications

Misoprostol-induced fever and genetic polymorphisms in drug transporters SLCO1B1 and ABCC4 in women of Latin American and European ancestry.

Authors:
Ana Alfirevic Jill Durocher Anisa Elati Wilfrido León David Dickens Steffen Rädisch Helen Box Marco Siccardi Paul Curley George Xinarianos Arjun Ardeshana Andrew Owen J Eunice Zhang Munir Pirmohamed Zarko Alfirevic Andrew Weeks Beverly Winikoff

Pharmacogenomics 2015 30;16(9):919-28. Epub 2015 Jun 30.

Gynuity Health Projects, NY, USA.

Aim: Misoprostol, a prostaglandin analogue used for the treatment of postpartum hemorrhage and termination of pregnancy, can cause high fevers. Genetic susceptibility may play a role in misoprostol-induced fever.

Subjects & Methods: Body temperature of women treated with misoprostol for termination of pregnancy in the UK (n = 107) and for postpartum hemorrhage in Ecuador (n = 50) was measured. Read More

View Article and Full-Text PDF
April 2016
Similar Publications

Abortion after deliberate Arthrotec® addition to food. Mass spectrometric detection of diclofenac, misoprostol acid, and their urinary metabolites.

Authors:
Bernhard Watzer Klaas J Lusthof Horst Schweer

Int J Legal Med 2015 Jul 19;129(4):759-69. Epub 2014 Dec 19.

Department of Pediatrics, Philipps University Marburg, Baldingerstrasse, 35043, Marburg, Germany,

Arthrotec(®) (AT) is a combination of diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), and misoprostol (MP), a synthetic analogue of prostaglandin E1 (PGE1). MP is a lipophilic methyl ester prodrug. It is readily metabolized to the biologically active misoprostol acid (MPA). Read More

View Article and Full-Text PDF
July 2015
Similar Publications

Validated method for the determination of misoprostol acid in whole blood by ultra performance liquid chromatography-tandem mass spectrometry.

Authors:
Susana Sadler Simões Antonio Castañera Ajenjo Mário João Dias

J Pharm Biomed Anal 2012 Dec 16;71:198-201. Epub 2012 Aug 16.

National Institute of Legal Medicine-South Branch, Rua Manuel Bento de Sousa n(o)3, 1169-201 Lisbon, Portugal.

Misoprostol is a pharmaceutical synthetic compound, analog of prostaglandin E1, frequently used as an abortifacient in not medically supervised or self-induced abortions, particularly in countries with restrictive abortion laws representing a serious public health problem. The aim of this study was to develop and validate a sensitive analytical method for the determination of misoprostol acid in whole blood samples. The samples were prepared by SPE and the chromatographic separation was performed by UPLC-MS/MS using ESI- and MRM mode with an Acquity UPLC(®) BEH C18 (50mm×2. Read More

View Article and Full-Text PDF
December 2012
Similar Publications